These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36728505)

  • 21. Artificial intelligence in drug discovery: recent advances and future perspectives.
    Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
    Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
    [No Abstract]   [Full Text] [Related]  

  • 22. Artificial intelligence in drug discovery: applications and techniques.
    Deng J; Yang Z; Ojima I; Samaras D; Wang F
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34734228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SmartCADD: AI-QM Empowered Drug Discovery Platform with Explainability.
    Madushanka A; Laird E; Clark C; Kraka E
    J Chem Inf Model; 2024 Sep; 64(17):6799-6813. PubMed ID: 39177478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of Artificial Intelligence in Drug Discovery.
    Chopra H; Baig AA; Gautam RK; Kamal MA
    Curr Pharm Des; 2022; 28(33):2690-2703. PubMed ID: 35676841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Review on Artificial Intelligence Approaches and Rational Approaches in Drug Discovery.
    Srivathsa AV; Sadashivappa NM; Hegde AK; Radha S; Mahesh AR; Ammunje DN; Sen D; Theivendren P; Govindaraj S; Kunjiappan S; Pavadai P
    Curr Pharm Des; 2023 Jun; 29(15):1180-1192. PubMed ID: 37132148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Success stories of AI in drug discovery - where do things stand?
    Mak KK; Balijepalli MK; Pichika MR
    Expert Opin Drug Discov; 2022 Jan; 17(1):79-92. PubMed ID: 34553659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.
    Shiammala PN; Duraimutharasan NKB; Vaseeharan B; Alothaim AS; Al-Malki ES; Snekaa B; Safi SZ; Singh SK; Velmurugan D; Selvaraj C
    Methods; 2023 Nov; 219():82-94. PubMed ID: 37778659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New avenues in artificial-intelligence-assisted drug discovery.
    Cerchia C; Lavecchia A
    Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug Intelligence Science (DIS®): Pioneering a high-resolution translational platform to enhance the probability of success for drug discovery and development.
    Schweizer L
    Drug Discov Today; 2023 Nov; 28(11):103795. PubMed ID: 37805064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial intelligence for drug discovery and development in Alzheimer's disease.
    Qiu Y; Cheng F
    Curr Opin Struct Biol; 2024 Apr; 85():102776. PubMed ID: 38335558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine.
    Pun FW; Leung GHD; Leung HW; Liu BHM; Long X; Ozerov IV; Wang J; Ren F; Aliper A; Izumchenko E; Moskalev A; de Magalhães JP; Zhavoronkov A
    Aging (Albany NY); 2022 Mar; 14(6):2475-2506. PubMed ID: 35347083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerating antibiotic discovery through artificial intelligence.
    Melo MCR; Maasch JRMA; de la Fuente-Nunez C
    Commun Biol; 2021 Sep; 4(1):1050. PubMed ID: 34504303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The AI-driven Drug Design (AIDD) platform: an interactive multi-parameter optimization system integrating molecular evolution with physiologically based pharmacokinetic simulations.
    Jones J; Clark RD; Lawless MS; Miller DW; Waldman M
    J Comput Aided Mol Des; 2024 Mar; 38(1):14. PubMed ID: 38499823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retro Drug Design: From Target Properties to Molecular Structures.
    Wang Y; Michael S; Yang SM; Huang R; Cruz-Gutierrez K; Zhang Y; Zhao J; Xia M; Shinn P; Sun H
    J Chem Inf Model; 2022 Jun; 62(11):2659-2669. PubMed ID: 35653613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificial Intelligence and Quantum Computing as the Next Pharma Disruptors.
    Cova T; Vitorino C; Ferreira M; Nunes S; Rondon-Villarreal P; Pais A
    Methods Mol Biol; 2022; 2390():321-347. PubMed ID: 34731476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Millennia-Long Development of Drugs Associated with the 80-Year-Old Artificial Intelligence Story: The Therapeutic Big Bang?
    Crouzet A; Lopez N; Riss Yaw B; Lepelletier Y; Demange L
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery.
    Han R; Yoon H; Kim G; Lee H; Lee Y
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rethinking drug design in the artificial intelligence era.
    Schneider P; Walters WP; Plowright AT; Sieroka N; Listgarten J; Goodnow RA; Fisher J; Jansen JM; Duca JS; Rush TS; Zentgraf M; Hill JE; Krutoholow E; Kohler M; Blaney J; Funatsu K; Luebkemann C; Schneider G
    Nat Rev Drug Discov; 2020 May; 19(5):353-364. PubMed ID: 31801986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?
    Zhavoronkov A; Vanhaelen Q; Oprea TI
    Clin Pharmacol Ther; 2020 Apr; 107(4):780-785. PubMed ID: 31957003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.